CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intuitive Surgical Inc   (NASDAQ: ISRG)
Other Ticker:  
 

 


Intuitive Surgical Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Intuitive Surgical Inc 's ROA in the first quarter of 2025?
Intuitive Surgical Inc achieved a return on average assets (ROA) of 13.79 % in its first quarter of 2025, which is below Intuitive Surgical Inc 's average return on assets, which stands at 14.48%.

ROA has improved compared to 13.56% in the fourth quarter of 2024, due to net income growth.

However, within the Healthcare sector 57 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 337, from total ROA ranking in the fourth quarter of 2024 at 386.

What is ROA?


Return On Assets (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Total Assets Change 21.43 % 21.38 % 20.6 % 19.74 % 21.26 %
Y / Y Net Income Change 28.55 % 12.66 % 35.92 % 24.77 % 51.72 %
Net Income (TTM) in million 2,494 2,338 2,260 2,109 2,004
Return On Assets (TTM) 13.79 % 13.56 % 13.77 % 13.47 % 13.38 %
ISRG's Total Ranking # 337 # 386 # 355 # 373 # 372
Total Assets (TTM) in million 19,222 18,744 17,745 16,651 15,830
Seq. Total Assets Change 2.55 % 5.63 % 6.57 % 5.19 % 2.51 %
Seq. Net Income Change 2.28 % 20.57 % 7.36 % -2.9 % -10.37 %

ISRG's 5 Years Annual ROA >> Back to ISRG Management Effectiveness >> Compare ISRG ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 14
Sector # 58
Overall # 335

Return On Assets Statistics
High Average Low
23.32 %
14.48 %
10.03 %
(March 31, 2007)   (Dec 31 2022)





Financial Statements
Intuitive Surgical Inc 's Assets $ 19,222 million ISRG's Balance sheet
Intuitive Surgical Inc 's Income $ 704 million Quarterly ISRG's Income Statement
ISRG's Income by Division See ISRG's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change 21.38 % 19.01 % -4.28 % 21.36 % 14.75 %
Total Assets in million 18,744 15,442 12,975 13,555 11,169
Y / Y Net Income Change 28.62 % 35.18 % -22.2 % 61.99 % -22.8 %
Net Income in million 2,338 1,817 1,344 1,728 1,067
Annual Return On Assets 12.47 % 11.77 % 10.36 % 12.75 % 9.55 %

ISRG's 5 Years Annual ROA >> Back to ISRG Management Effectiveness >> Compare ISRG ROA to its Competitors



Comment on ISRG's ROA in the fiscal year ending 2024
In the fiscal year 2024 ROA improved to 12.47 % compared to prior year, due to annual net income growth of 28.62 % to $2,337.50 million, while value of Intuitive Surgical Inc 's overall assets grew just by 21.38 % to $18,744.20 million, compared to $18,744.20 a year before.


More Return On Assets Ratios
ISRG's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ISRG's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for ISRG's Competitors
Roa for Intuitive Surgical Inc 's Suppliers
Return On Assets for ISRG's Customers

You may also want to know
ISRG's Roi ISRG's Inventory Turnover Ratio ISRG's Growth Rates ISRG's Dividend Comparisons
ISRG's Profitability Ratios ISRG's Asset Turnover Ratio ISRG's Dividend Growth
ISRG's Roe ISRG's Valuation Ratios ISRG's Financial Strength Ratios ISRG's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA
Seres Therapeutics Inc   36.27 %
Edwards Lifesciences Corporation  33.98 %
Ptc Therapeutics inc   33.77 %
Cytomx Therapeutics Inc   32.17 %
Sbc Medical Group Holdings Incorporated  31.60 %
Bluebird Bio Inc   31.57 %
Novavax inc   29.99 %
Idexx Laboratories Inc  26.97 %
Mettler Toledo International Inc  26.04 %
Hims and Hers Health Inc   24.52 %
Rigel Pharmaceuticals Inc  24.47 %
Catalyst Pharmaceuticals Inc   24.37 %
Acadia Pharmaceuticals Inc   23.61 %
Halozyme Therapeutics Inc   23.26 %
Lipocine Inc   22.11 %
Siga Technologies Inc  22.07 %
Medpace Holdings Inc   20.81 %
Carlisle Companies Incorporated  20.64 %
Iradimed Corporation  20.60 %
Third Harmonic Bio Inc   18.67 %
National Research Corporation  18.67 %
Abbott Laboratories  18.35 %
Resmed Inc   18.24 %
Puma Biotechnology Inc   18.23 %
Chemed Corporation  17.90 %
Zoetis Inc   17.78 %
United Therapeutics Corporation  16.73 %
Corcept Therapeutics Inc  16.64 %
Alkermes Plc   16.60 %
Pro dex Inc   16.19 %

Date modified: 2025-04-24T01:33:51+00:00


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com